By Anonna Dutt | Hindustan Times, New Delhi, New Delhi
UPDATED ON SEP 23, 2020 11:51 PM IST
The institute had identified first three combination therapies, for Phase 3 clinical trials, based on computational modelling of molecules and laboratory-based data. Another five combinations are also in the works and will be finalised after preliminary data for the same is received.
Enter your email to get our daily newsletter in your inbox
Get our daily newsletter in your inbox
Thank you for subscribing to our daily newsletter.